The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study

od Getaneh, Abraham M., Heijnsdijk, Eveline A. M., de Koning, Harry J.
izdano v Sci Rep (2021)

Estimating the risks and benefits of Active Surveillance protocols for Prostate Cancer: A microsimulation study

od de Carvalho, Tiago M., Heijnsdijk, Eveline A.M., de Koning, Harry J.
izdano v BJU Int (2016)

Screening for Prostate Cancer in the US? Reduce the harms and keep the benefit

od de Carvalho, Tiago M., Heijnsdijk, Eveline A.M., de Koning, Harry J.
izdano v Int J Cancer (2014)

Comparative effectiveness of prostate cancer screening between ages 55 and 69 followed by Active Surveillance.

od de Carvalho, Tiago M., Heijnsdijk, Eveline A.M., de Koning, Harry J.
izdano v Cancer (2017)

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening

od Wever, Elisabeth M., Draisma, Gerrit, Heijnsdijk, Eveline A.M., de Koning, Harry J.
izdano v Med Decis Making (2011)

Evaluating parameter uncertainty in a simulation model of cancer using emulators.

od de Carvalho, Tiago M., Heijnsdijk, Eveline A.M., Coffeng, Luc, de Koning, Harry J.
izdano v Med Decis Making (2019)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

od Getaneh, Abraham M., Heijnsdijk, Eveline A. M., Roobol, Monique J., de Koning, Harry J.
izdano v Cancer Med (2020)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer

od Heijnsdijk, Eveline A. M., Supit, Steven J., Looijenga, Leendert H. J., de Koning, Harry J.
izdano v Cancer Med (2021)

Informed decision-making based on a leaflet in the context of prostate cancer screening

od Dierks, Tessa, Heijnsdijk, Eveline A.M., Korfage, Ida J., Roobol, Monique J., de Koning, Harry J.
izdano v Patient Educ Couns (2019)

The impact of design and performance in PSA screening: differences between ERSPC centers

od Heijnsdijk, Eveline A.M., Adolfsson, Jan, Auvinen, Anssi, Roobol, Monique J., Hugosson, Jonas, de Koning, Harry J.
izdano v Eur Urol (2019)

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening

od de Gelder, Rianne, Heijnsdijk, Eveline A. M., van Ravesteyn, Nicolien T., Fracheboud, Jacques, Draisma, Gerrit, de Koning, Harry J.
Izdano 2011

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer

od Heijnsdijk, Eveline A.M., Nieboer, Daan, Garg, Tullika, Lansdorp‐Vogelaar, Iris, de Koning, Harry J., Nielsen, Matthew E.
izdano v BJU Int (2018)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk

od Geuzinge, H. Amarens, Heijnsdijk, Eveline A.M., Obdeijn, Inge-Marie, de Koning, Harry J., Tilanus-Linthorst, Madeleine M.A.
izdano v Breast (2021)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam

od Wever, Elisabeth M., Draisma, Gerrit, Heijnsdijk, Eveline A. M., Roobol, Monique J., Boer, Rob, Otto, Suzie J., de Koning, Harry J.
Izdano 2010

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study

od Heijnsdijk, Eveline A. M., Csanádi, Marcell, Gini, Andrea, ten Haaf, Kevin, Bendes, Rita, Anttila, Ahti, Senore, Carlo, de Koning, Harry J.
izdano v Cancer Med (2019)

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios

od Zielonke, Nadine, Geuzinge, Amarens, Heijnsdijk, Eveline A. M., Heinävaara, Sirpa, Senore, Carlo, Jarm, Katja, de Koning, Harry J., van Ravesteyn, Nicolien T.
izdano v Cancers (Basel) (2021)

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer

od Heijnsdijk, Eveline A M, Gulati, Roman, Tsodikov, Alex, Lange, Jane M, Mariotto, Angela B, Vickers, Andrew J, Carlsson, Sigrid V, Etzioni, Ruth
izdano v J Natl Cancer Inst (2020)

Race-Specific Impact of Natural History, Mammography Screening and Adjuvant Treatment on Breast Cancer Mortality Rates in the US

od van Ravesteyn, Nicolien T., Schechter, Clyde B., Near, Aimee M., Heijnsdijk, Eveline A.M., Stoto, Michael A., Draisma, Gerrit, de Koning, Harry J., Mandelblatt, Jeanne S.
Izdano 2010

Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis

od van Ravesteyn, Nicolien T., Stout, Natasha K., Schechter, Clyde B., Heijnsdijk, Eveline A. M., Alagoz, Oguzhan, Trentham-Dietz, Amy, Mandelblatt, Jeanne S., de Koning, Harry J.
izdano v J Natl Cancer Inst (2015)

Is prostate cancer different in black men? Answers from three natural history models

od Tsodikov, Alex, Gulati, Roman, de Carvalho, Tiago M., Heijnsdijk, Eveline A. M., Hunter-Merrill, Rachel A., Mariotto, Angela B., de Koning, Harry J., Etzioni, Ruth
izdano v Cancer (2017)